Literature DB >> 16439550

Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.

Miki Kawada1, Hiroko Igarashi, Akiko Takeda, Tetsuo Tsukamoto, Hiroyuki Yamamoto, Sachi Dohki, Masafumi Takiguchi, Tetsuro Matano.   

Abstract

Cytotoxic T-lymphocyte (CTL) responses are crucial for the control of immunodeficiency virus replication. Possible involvement of a dominant single epitope-specific CTL in control of viral replication has recently been indicated in preclinical AIDS vaccine trials, but it has remained unclear if multiple epitope-specific CTLs can be involved in the vaccine-based control. Here, by following up five rhesus macaques that showed vaccine-based control of primary replication of a simian immunodeficiency virus, SIVmac239, we present evidence indicating involvement of multiple epitope-specific CTL responses in this control. Three macaques maintained control for more than 2 years without additional mutations in the provirus. However, in the other two that shared a major histocompatibility complex haplotype, viral mutations were accumulated in a similar order, leading to viral evasion from three epitope-specific CTL responses with viral fitness costs. Accumulation of these multiple escape mutations resulted in the reappearance of plasma viremia around week 60 after challenge. Our results implicate multiple epitope-specific CTL responses in control of immunodeficiency virus replication and furthermore suggest that sequential accumulation of multiple CTL escape mutations, if allowed, can result in viral evasion from this control.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439550      PMCID: PMC1367167          DOI: 10.1128/JVI.80.4.1949-1958.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

Review 1.  HIV vaccines 1983-2003.

Authors:  Andrew J McMichael; Tomas Hanke
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

2.  Gradual adaptation of HIV to human host populations: good or bad news?

Authors:  Christian Brander; Bruce D Walker
Journal:  Nat Med       Date:  2003-11       Impact factor: 53.440

Review 3.  HIV and SIV CTL escape: implications for vaccine design.

Authors:  Philip J R Goulder; David I Watkins
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

4.  Reversion of CTL escape-variant immunodeficiency viruses in vivo.

Authors:  Thomas C Friedrich; Elizabeth J Dodds; Levi J Yant; Lara Vojnov; Richard Rudersdorf; Candice Cullen; David T Evans; Ronald C Desrosiers; Bianca R Mothé; John Sidney; Alessandro Sette; Kevin Kunstman; Steven Wolinsky; Michael Piatak; Jeffrey Lifson; Austin L Hughes; Nancy Wilson; David H O'Connor; David I Watkins
Journal:  Nat Med       Date:  2004-02-15       Impact factor: 53.440

5.  Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response.

Authors:  Thomas C Friedrich; Christopher A Frye; Levi J Yant; David H O'Connor; Nancy A Kriewaldt; Meghan Benson; Lara Vojnov; Elizabeth J Dodds; Candice Cullen; Richard Rudersdorf; Austin L Hughes; Nancy Wilson; David I Watkins
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

6.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

Authors:  H W Kestler; D J Ringler; K Mori; D L Panicali; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

7.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

8.  HIV evolution: CTL escape mutation and reversion after transmission.

Authors:  A J Leslie; K J Pfafferott; P Chetty; R Draenert; M M Addo; M Feeney; Y Tang; E C Holmes; T Allen; J G Prado; M Altfeld; C Brander; C Dixon; D Ramduth; P Jeena; S A Thomas; A St John; T A Roach; B Kupfer; G Luzzi; A Edwards; G Taylor; H Lyall; G Tudor-Williams; V Novelli; J Martinez-Picado; P Kiepiela; B D Walker; P J R Goulder
Journal:  Nat Med       Date:  2004-02-08       Impact factor: 53.440

9.  Simian-human immunodeficiency virus escape from cytotoxic T-lymphocyte recognition at a structurally constrained epitope.

Authors:  Fred W Peyerl; Dan H Barouch; Wendy W Yeh; Heidi S Bazick; Jennifer Kunstman; Kevin J Kunstman; Steven M Wolinsky; Norman L Letvin
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.

Authors:  Tetsuro Matano; Masahiro Kobayashi; Hiroko Igarashi; Akiko Takeda; Hiromi Nakamura; Munehide Kano; Chie Sugimoto; Kazuyasu Mori; Akihiro Iida; Takahiro Hirata; Mamoru Hasegawa; Takae Yuasa; Masaaki Miyazawa; Yumiko Takahashi; Michio Yasunami; Akinori Kimura; David H O'Connor; David I Watkins; Yoshiyuki Nagai
Journal:  J Exp Med       Date:  2004-06-21       Impact factor: 14.307

View more
  29 in total

1.  Impact of vaccination on cytotoxic T lymphocyte immunodominance and cooperation against simian immunodeficiency virus replication in rhesus macaques.

Authors:  Hiroshi Ishii; Miki Kawada; Tetsuo Tsukamoto; Hiroyuki Yamamoto; Saori Matsuoka; Teiichiro Shiino; Akiko Takeda; Makoto Inoue; Akihiro Iida; Hiroto Hara; Tsugumine Shu; Mamoru Hasegawa; Taeko K Naruse; Akinori Kimura; Masafumi Takiguchi; Tetsuro Matano
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity.

Authors:  Jaclyn K Wright; Vanessa L Naidoo; Zabrina L Brumme; Jessica L Prince; Daniel T Claiborne; Philip J R Goulder; Mark A Brockman; Eric Hunter; Thumbi Ndung'u
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

3.  Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.

Authors:  Miki Kawada; Tetsuo Tsukamoto; Hiroyuki Yamamoto; Akiko Takeda; Hiroko Igarashi; David I Watkins; Tetsuro Matano
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

4.  Control of simian immunodeficiency virus replication by vaccine-induced Gag- and Vif-specific CD8+ T cells.

Authors:  Nami Iwamoto; Naofumi Takahashi; Sayuri Seki; Takushi Nomura; Hiroyuki Yamamoto; Makoto Inoue; Tsugumine Shu; Taeko K Naruse; Akinori Kimura; Tetsuro Matano
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

5.  Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection.

Authors:  Vitaly V Ganusov; Nilu Goonetilleke; Michael K P Liu; Guido Ferrari; George M Shaw; Andrew J McMichael; Persephone Borrow; Bette T Korber; Alan S Perelson
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

6.  Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection.

Authors:  Mauricio A Martins; Damien C Tully; Michael A Cruz; Karen A Power; Marlon G Veloso de Santana; David J Bean; Colin B Ogilvie; Rujuta Gadgil; Noemia S Lima; Diogo M Magnani; Keisuke Ejima; David B Allison; Michael Piatak; John D Altman; Christopher L Parks; Eva G Rakasz; Saverio Capuano; Ricardo Galler; Myrna C Bonaldo; Jeffrey D Lifson; Todd M Allen; David I Watkins
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

7.  The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape.

Authors:  John T Loffredo; Benjamin J Burwitz; Eva G Rakasz; Sean P Spencer; Jason J Stephany; Juan Pablo Giraldo Vela; Sarah R Martin; Jason Reed; Shari M Piaskowski; Jessica Furlott; Kim L Weisgrau; Denise S Rodrigues; Taeko Soma; Gnankang Napoé; Thomas C Friedrich; Nancy A Wilson; Esper G Kallas; David I Watkins
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

8.  Gag-specific cytotoxic T-lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial.

Authors:  Miki Kawada; Tetsuo Tsukamoto; Hiroyuki Yamamoto; Nami Iwamoto; Kyoko Kurihara; Akiko Takeda; Chikaya Moriya; Hiroaki Takeuchi; Hirofumi Akari; Tetsuro Matano
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients.

Authors:  Hayley Crawford; Wendy Lumm; Alasdair Leslie; Malinda Schaefer; Debrah Boeras; Julia G Prado; Jianming Tang; Paul Farmer; Thumbi Ndung'u; Shabir Lakhi; Jill Gilmour; Paul Goepfert; Bruce D Walker; Richard Kaslow; Joseph Mulenga; Susan Allen; Philip J R Goulder; Eric Hunter
Journal:  J Exp Med       Date:  2009-03-23       Impact factor: 14.307

10.  Sang Froid in a time of trouble: is a vaccine against HIV possible?

Authors:  Stanley A Plotkin
Journal:  J Int AIDS Soc       Date:  2009-02-02       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.